Parotitis and Orchitis Cases due to Measles-Mumps-Rubella Vaccine

被引：1
|
作者：
Sultanova, Fidan [1 ]
Ozger, Hasan Selcuk [1 ]
Ozer, Fatma [1 ]
Yildiz, Yesim [1 ]
Senol, Esin [1 ]
机构：
[1] Gazi Univ, Tip Fak, Infeks Hastaliklari & Klin Mikrobiyol Anabilim, Ankara, Turkey
来源：
KLIMIK JOURNAL | 2022年 / 35卷 / 01期
关键词：
mumps; MMR vaccine; Parotitis; Orchitis; Vaccine Adverse Events;
D O I：
10.36519/kd.2022.3922
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Although it is known that parotitis and orchitis cases may develop due to mumps strain included in the MMR vaccine, it has been shown that vaccines containing L-Z mumps strains may be associated with these side effects more frequently. In this article, we evaluated vaccine-related parotitis and orchitis cases in healthcare workers after measles-mumps -ru-bella (MMR) vaccine containing Edmonston-Zagreb measles, Leningrad-Zagreb mumps and Wistar Ra 27/3 measles strains. Twelve mumps seronegative healthcare workers developed parotitis and orchitis after the MMR vaccine con-taining L-Z mumps strain. The cases were confirmed serologically with mumps IgM positivity
引用
收藏
页码：46 / 48
页数：3
相关论文
共 50 条
  • [41] Thrombocytopenia and measles-mumps-rubella (MMR) vaccine: Managing loss of immunity to MMR
    Collins, L. C., Jr.
    Minor, M. C.
    Blacker, N. C.
    Robinson, G. J.
    Engler, R. J. M.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S97 - S97
  • [42] Administration of measles-mumps-rubella vaccine (MMR) in egg-allergic children
    Dimitriou, AND
    Syrigou, EKS
    Tapranzi, PT
    Manousakis, MM
    Baka, GB
    Zanikou, SZ
    Psarros, PP
    Papageorgiou, PSPS
    ALLERGY, 2002, 57 : 209 - 209
  • [43] Erytherna Multiforme following live attenuated trivalent measles-mumps-rubella vaccine
    Bernardini, Maria Luisa
    D'Angelo, Gianfranco
    Oggiano, Nicola
    Campanati, Anna
    Ficcadenti, Anna
    Coppa, Giovanni Valentino
    Offidani, Annamaria
    ACTA DERMATO-VENEREOLOGICA, 2006, 86 (04) : 359 - 360
  • [44] DECREASED MEASLES ANTIBODY-RESPONSE AFTER MEASLES-MUMPS-RUBELLA VACCINE IN INFANTS WITH COLDS
    KROBER, MS
    STRACENER, CE
    BASS, JW
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (16): : 2095 - 2096
  • [45] Surveillance of measles-mumps-rubella vaccine-Associated aseptic meningitis in Germany
    Schlipköter, U
    Mühlberger, N
    von Kries, R
    Weil, J
    INFECTION, 2002, 30 (06) : 351 - 355
  • [46] Reply to Ozdemir, "Measles-Mumps-Rubella Vaccine and COVID-19 Relationship"
    Fidel, Paul L., Jr.
    Noverr, Mairi C.
    MBIO, 2020, 11 (05):
  • [47] MEASLES-MUMPS-RUBELLA VACCINE PRELIMINARY-RESULTS OF A MASS VACCINATION CAMPAIGN
    BONA, G
    ZAFFARONI, M
    CIGOLOTTI, AC
    CRIVELLI, S
    RUGGENINI, AM
    ZOTTI, C
    LEONARDI, G
    JODICE, E
    RIVISTA ITALIANA DI PEDIATRIA-ITALIAN JOURNAL OF PEDIATRICS, 1993, 19 (02): : 134 - 137
  • [48] THE MEASLES-MUMPS-RUBELLA VACCINATION PROGRAM IN FINLAND
    LERMAN, SJ
    NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (16): : 1103 - 1103
  • [49] Anticancer Activity of Measles-Mumps-Rubella MMR Vaccine Viruses against Glioblastoma
    Khalid, Zumama
    Coco, Simona
    Ullah, Nadir
    Pulliero, Alessandra
    Cortese, Katia
    Varesano, Serena
    Orsi, Andrea
    Izzotti, Alberto
    CANCERS, 2023, 15 (17)
  • [50] Immunogenicity of second dose measles-mumps-rubella (MMR) vaccine and implications for serosurveillance
    Pebody, RG
    Gay, NJ
    Hesketh, LM
    Vyse, A
    Morgan-Capner, P
    Brown, DW
    Litton, P
    Miller, E
    VACCINE, 2002, 20 (7-8) : 1134 - 1140
12345